Adbry

Tralokinumab-Ldrm

7.8 High risk

Adbry & Injection site pain

35.3%

of users reported Injection site pain

100.0%

also reported Severe reaction

91.7%

are women

Most common medical consequences

Severe reaction
100.0%

Have you experienced any negative side effects from this medication?

Adbry: general information

Most common side effects (4)

Most commonly affected ages

30 - 39 years
19.6%
40 - 49 years
<0.1%
50 - 59 years
<0.1%
60 - 69 years
35.7%
70 - 79 years
44.6%